You are here

Article Text

Article menu

This article has a correction. Please see:

Download PDFPDF
Letter
Meningioma of the optic nerve sheath: treatment with hydroxyurea
  1. S Paus1,
  2. T Klockgether1,
  3. U Schlegel1,
  4. H Urbach2
  1. 1Department of Neurology, University of Bonn, Sigmund-Freud-Strasse 25, 53105 Bonn, Germany
  2. 2Department of Radiology, University of Bonn
  1. Correspondence to:
 Professor Dr U Schlegel; 
 uwe.schlegel{at}uni-bonn.de

https://doi.org/10.1136/jnnp.74.9.1348-a

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The best treatment of optic nerve sheath meningiomas remains controversial. Recent reports have emphasised the efficacy of fractionated stereotactic or conformal radiotherapy, and some clinicians favour this approach instead of surgery or observation.1,2 On the other hand, a beneficial effect of hydroxyurea on unresectable, residual, and recurrent meningiomas has been reported in various series.3–5 We report a patient with a meningioma of the optic nerve sheath and nearly complete visual loss who was successfully treated with hydroxyurea alone.

    Case report

    A 46 year old woman presented with painless and progressive right sided visual failure for two years. On admittance, visual acuity of the right eye was 0.05. In addition, there was an afferent pupillary defect, and swelling of the optic disc. Otherwise, the neurological examination was normal. Cranial magnetic resonance imaging (MRI) revealed a homogeneously enhancing, fusiform tumour (5 × …

    View Full Text